secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fortress Biotech, Inc. (FBIO)
CIK:        0001429260
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001558370-23-011384
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fortress Biotech stockholders approve 7M share increase in incentive plan and 1M in ESPP
--------------------------------------------------------------------------------

- Stockholders re-elected all eight director nominees to hold office until the 2024 annual meeting.
- Ratified KPMG as independent auditor for 2023 with over 99.6% of votes in favor.
- Approved amendment to 2013 Stock Incentive Plan: shares increased by 7M to 23M total, term extended to Dec 31, 2033.
- Approved amendment to 2012 ESPP: shares increased by 1M to 2M total.
- Both plan amendments became effective upon stockholder approval on June 21, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1429260/000155837023011384/0001558370-23-011384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1429260/000155837023011384/fbio-20230621x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer